Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah R Amend

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
The Prostate|February 27, 2024
Cancer cells employ lipid droplets to survive toxic stressLaurie G Kostecka, Sabrina Mendez, Melvin Li, et al.
Biochemistry and Biophysics Reports|July 21, 2025
Human hair as a diagnostic tool in medicineVenetia A Florou, Auraya Manaprasertsak, Maria Slyusarenko, et al.
Neoplasia (New York, N.Y.)|August 8, 2022
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotypeAmber E de Groot, Kayla V Myers, Timothy E G Krueger, et al.
Medical Oncology (Northwood, London, England)|August 29, 2023
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancerKayla V Myers Chen, Amber E de Groot, Sabrina A Mendez, et al.
The Prostate|August 4, 2019
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistanceSarah R Amend, Gonzalo Torga, Ke-Chih Lin, et al.
Neoplasia (New York, N.Y.)|January 22, 2026
Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic statusAnna Lk Gonye, Linda Orzolek, Christopher Cherry, et al.
BJU International|March 3, 2020
The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancerLiang Dong, Zhongyuan Zhang, Kimberly Smith, et al.
Scientific Reports|January 6, 2026
Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentationMelvin Li, Chenille A McCullum, Louis T A Rolle, et al.
Molecular Cancer Research : MCR|October 7, 2018
AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate CancerHaley D Axelrod, Kenneth C Valkenburg, Sarah R Amend, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentationMelvin Li, Chenille A McCullum, Louis T A Rolle, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
The Prostate|February 27, 2024
Cancer cells employ lipid droplets to survive toxic stressLaurie G Kostecka, Sabrina Mendez, Melvin Li, et al.
Biochemistry and Biophysics Reports|July 21, 2025
Human hair as a diagnostic tool in medicineVenetia A Florou, Auraya Manaprasertsak, Maria Slyusarenko, et al.
Neoplasia (New York, N.Y.)|August 8, 2022
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotypeAmber E de Groot, Kayla V Myers, Timothy E G Krueger, et al.
Medical Oncology (Northwood, London, England)|August 29, 2023
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancerKayla V Myers Chen, Amber E de Groot, Sabrina A Mendez, et al.
The Prostate|August 4, 2019
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistanceSarah R Amend, Gonzalo Torga, Ke-Chih Lin, et al.
Neoplasia (New York, N.Y.)|January 22, 2026
Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic statusAnna Lk Gonye, Linda Orzolek, Christopher Cherry, et al.
BJU International|March 3, 2020
The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancerLiang Dong, Zhongyuan Zhang, Kimberly Smith, et al.
Scientific Reports|January 6, 2026
Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentationMelvin Li, Chenille A McCullum, Louis T A Rolle, et al.
Molecular Cancer Research : MCR|October 7, 2018
AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate CancerHaley D Axelrod, Kenneth C Valkenburg, Sarah R Amend, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Cancer cells surviving cisplatin chemotherapy increase stress-induced OMA1 activity and mitochondrial fragmentationMelvin Li, Chenille A McCullum, Louis T A Rolle, et al.
Pageof 10